• 1
    Asioli S, Erickson LA, Sebo TJ, et al. Papillary thyroid carcinoma with prominent hobnail features: A new aggressive variant of moderately differentiated papillary carcinoma. A clinicopathologic, immunohistochemical, and molecular study of eight cases. Am J Surg Pathol 2010;34:4452.
  • 2
    Lloyd RV, Erickson LA, Asioli S. Papillary Thyroid carcinoma with prominent hobnail features: A new aggressive variant of moderately differentiated papillary carcinoma. A clinicopathologic, immunohistochemical, and molecular study of 8 cases. Am J Surg Pathol 2010;34:914.
  • 3
    Asioli S, Erickson LA, Righi A, Lloyd RV. Papillary thyroid carcinoma with hobnail features: Histopathologic criteria to predict aggressive behavior. Hum Pathol, 2013;44:320328.
  • 4
    Bellevicine C, Cozzolino I, Malapelle U, Zeppa P, Troncone G. Cytological and molecular features of papillary thyroid carcinoma with prominent hobnail features: A case report. Acta Cytol 2012;56:560564.
  • 5
    Yang GC, Fried K, Scognamiglio T. Cytological features of clear cell thyroid tumors, including a papillary thyroid carcinoma with prominent hobnail features. Diagn Cytopathol, 2012 Nov 16. doi: 10.1002/dc.22935. [Epub ahead of print].
  • 6
    British Thyroid Association, Royal College of Physicians. Fine needle aspiration cytology. In: Perros P, editor. Guidelines for the management of thyroid cancer. Report of the Thyroid Cancer Guidelines Update Group. 2nd ed. London: Royal College of Physicians; 2007. p 910.
  • 7
    Cibas ES, Ali SZ. NCI Thyroid FNA State of the Science Conference. The Bethesda System for reporting thyroid cytopathology. Am J Clin Pathol 2009;132:658665.
  • 8
    Asioli S, Bussolati G. Emerin immunohistochemistry reveals diagnostic features of nuclear membrane arrangement in thyroid lesions. Histopathology 2009;54:571579.
  • 9
    Asioli S, Maletta F, Pacchioni D, Lupo R, Bussolati G. Cytological detection of papillary thyroid carcinomas by nuclear membrane decoration with emerin staining. Virchows Arch 2010;457:4351.
  • 10
    Peterse JL. Breast carcinoma with an unexpected inside out pattern. Rotation of polarization associated with angioinvasion. Pathol Res Pract 1993;189:780.
  • 11
    Lee AH, Paish EC, Marchio C, et al. The expression of Wilms' tumour-1 and Ca125 in invasive micropapillary carcinoma of the breast. Histopathology 2007;51:824828.
  • 12
    Jin L, Sebo TJ, Nakamura N, et al. BRAF mutation analysis in fine needle aspiration (FNA) cytology of the thyroid. Diagn Mol Pathol 2006;15:136143.
  • 13
    American Joint Committee on Cancer. AJCC cancer staging manual. 7th ed. New York: Springer; 2010.
  • 14
    Asioli S, Erickson LA, Righi A, et al. Poorly differentiated carcinoma of the thyroid: validation of the Turin proposal and analysis of IMP3 expression. Mod Pathol 2010;23:12691278.
  • 15
    Volante M, Rapa I, Gandhi M, et al. RAS mutations are the predominant molecular alteration in poorly differentiated thyroid carcinomas and bear prognostic impact. J Clin Endocrinol Metab 2009;94:47354741.
  • 16
    Nikiforov Nikiforova MN, Nikiforov YE. Molecular genetics of thyroid cancer: Implications for diagnosis, treatment and prognosis. Expert Rev Mol Diagn 2008;8:8395.
  • 17
    Rosai J, Carcangiu ML, DeLellis RA. Tumors of the thyroid gland. Atlas of tumor pathology. Third Series. Fascicle 5. Washington, DC: Armed Forces Institute of Pathology; 1992.
  • 18
    Kini SR. Guides to clinical aspiration biopsy thyroid. 2nd ed. New York: Igaku-Shoin; 1996.
  • 19
    Solomon A, Gupta PK, LiVolsi VA, Baloch ZW. Distinguishing tall cell variant of papillary thyroid carcinoma from usual variant of papillary thyroid carcinoma in cytologic specimens. Diagn Cytopathol 2002;27:143148.
  • 20
    Chung AY, Tran TB, Brumund KT, Weisman RA, Bouvet M. Metastases to the thyroid: Review of the literature from the last decade. Thyroid 2012;22:258268.
  • 21
    Lee KR, Tavassoli FA, Prat J, et al. Surface epithelial-stromal tumours. In: Tavassoli FA, Devillee P, editors. World Health Organization classification of tumours. Pathology and genetics. Tumours of the breast and female genital organs. Lyon, France: IARC Press; 2003.p 117145.
  • 22
    Foyle A, Al-Jabi M, McCaughey WT. Papillary peritoneal tumors in women. Am J Surg Pathol 1981;5:241249.
  • 23
    Ninomiya H, Hiramatsu M, Inamura K, et al. Correlation between morphology and EGFR mutations in lung adenocarcinomas: Significance of the micropapillary pattern and the hobnail cell type. Lung Cancer 2009;63:235240.
  • 24
    Nassar H. Carcinomas with micropapillary morphology: Clinical significance and current concepts. Adv Anat Pathol 2004;11:297303.
  • 25
    Lennard TW, Wadehra V, Farndon JR. Fine needle aspiration biopsy in diagnosis of metastases to thyroid gland. J R Soc Med 1984;77:196197.
  • 26
    Gorla S, Di Bella C, Leone B, Pagni F. Cytological and histological findings of thyroid florid papillary hyperplasia. Cytopathology 2012;23:417419.
  • 27
    Ueng SH, Mezzetti T, Tavassoli FA. Papillary neoplasms of the breast: A review. Arch Pathol Lab Med 2009;133:893907.
  • 28
    Travis WD, Brambilla E, Noguchi M, et al. International association for the study of lung cancer/American thoracic society/European respiratory society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol 2011;6:244285.
  • 29
    Ushiku T, Matsusaka K, Iwasaki Y, et al. Gastric carcinoma with invasive micropapillary pattern and its association with lymph node metastasis. Histopathology 2011;59:10811089.
  • 30
    Verdú M, Román R, Calvo M, et al. Clinicopathological and molecular characterization of colorectal micropapillary carcinoma. Mod Pathol 2011;24:729738.
  • 31
    Nikiforova MN, Nikiforov YE. Molecular diagnostics and predictors in thyroid cancer. Thyroid 2009;19:13511361.
  • 32
    Moses W, Weng J, Sansano I, Peng M, Khanafshar E, Ljung BM, et al. Molecular testing for somatic mutations improves the accuracy of thyroid fine-needle aspiration biopsy. World J Surg 2010;34:25892594.